Literature DB >> 22481105

Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.

Sanae Hamaguchi1, Shintaro Kinugawa, Mochamad Ali Sobirin, Daisuke Goto, Miyuki Tsuchihashi-Makaya, Satoshi Yamada, Hisashi Yokoshiki, Hiroyuki Tsutsui.   

Abstract

BACKGROUND: The mode of death has not been investigated in the registry data of patients with heart failure and reduced ejection fraction (HFREF) vs. preserved ejection fraction (HFPEF). The aim of the present study was therefore to carry out this comparison. METHODS AND
RESULTS: The Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD) prospectively studied the characteristics and treatments in a broad sample of 2,675 patients hospitalized with worsening HF, and followed them for an average of 2.1 years. This study included 323 patients in whom information on both the mode of death and left ventricular EF on echocardiography could be obtained. The mode of death was cardiovascular (CV) in 63% (including 17% sudden, 36% HF, 3% myocardial infarction, and 3% stroke), non-CV in 23%, and unknown in 14%. The prevalence of CV death including sudden death was high in patients with HFREF compared to HFPEF (68% vs. 58%, P=0.020). HF death, the most common mode of death, was similar between groups (37% vs. 35%, P=0.694). In contrast, non-CV mortality was significantly higher in HFPEF than those with HFREF (28% vs. 18%, P=0.021).
CONCLUSIONS: In 60-70% of deaths the mode was CV, and HF death was the most common mode of death in either HFREF or HFPEF. The prevalence of sudden death was lower, and that of non-CV death higher, in HFPEF compared with HFREF.

Entities:  

Mesh:

Year:  2012        PMID: 22481105     DOI: 10.1253/circj.cj-11-1355

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  22 in total

Review 1.  Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.

Authors:  Frank P Brouwers; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Curr Heart Fail Rep       Date:  2012-12

Review 2.  The baroreceptor as a therapeutic target for heart failure.

Authors:  Edoardo Gronda; Eric G Lovett; Michela Tarascio; Dimitrios Georgakopoulos; Guido Grassi; Emilio Vanoli
Journal:  J Cardiovasc Transl Res       Date:  2014-02-22       Impact factor: 4.132

3.  Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication.

Authors:  Masanori Suzuki; Yuya Matsue; Sayaka Izumi; Ayako Kimura; Tomoaki Hashimoto; Kentaro Otomo; Hiroshi Saito; Makoto Suzuki; Yasuhisa Kato; Ryohkan Funakoshi
Journal:  Heart Vessels       Date:  2017-12-04       Impact factor: 2.037

Review 4.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Shannon M Dunlay; Véronique L Roger; Margaret M Redfield
Journal:  Nat Rev Cardiol       Date:  2017-05-11       Impact factor: 32.419

Review 5.  Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?

Authors:  Muthiah Vaduganathan; Ravi B Patel; Sanjiv J Shah; Javed Butler
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 6.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Abhinav Dhingra; Aayushi Garg; Simrat Kaur; Saurav Chopra; Jaspreet Singh Batra; Ambarish Pandey; Antoine H Chaanine; Sunil K Agarwal
Journal:  Curr Heart Fail Rep       Date:  2014-12

7.  Modes of death in patients with heart failure and preserved ejection fraction.

Authors:  Stefan Aschauer; Caroline Zotter-Tufaro; Franz Duca; Andreas Kammerlander; Daniel Dalos; Julia Mascherbauer; Diana Bonderman
Journal:  Int J Cardiol       Date:  2016-11-18       Impact factor: 4.164

Review 8.  Sudden Cardiac Death in Patients with Heart Disease and Preserved Systolic Function: Current Options for Risk Stratification.

Authors:  Luigi Pannone; Giulio Falasconi; Lorenzo Cianfanelli; Luca Baldetti; Francesco Moroni; Roberto Spoladore; Pasquale Vergara
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

Review 9.  Mortality in heart failure patients.

Authors:  Ibadete Bytyçi; Gani Bajraktari
Journal:  Anatol J Cardiol       Date:  2014-08-19       Impact factor: 1.596

10.  Risk stratification for sudden cardiac death: current status and challenges for the future.

Authors:  Hein J J Wellens; Peter J Schwartz; Fred W Lindemans; Alfred E Buxton; Jeffrey J Goldberger; Stefan H Hohnloser; Heikki V Huikuri; Stefan Kääb; Maria Teresa La Rovere; Marek Malik; Robert J Myerburg; Maarten L Simoons; Karl Swedberg; Jan Tijssen; Adriaan A Voors; Arthur A Wilde
Journal:  Eur Heart J       Date:  2014-05-05       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.